Jean I. Liu J.D., M.S.
Net Worth

Last updated:

What is Jean I. Liu J.D., M.S. net worth?

The estimated net worth of Ms. Jean I. Liu J.D., M.S. is at least $20,575,998 as of 21 Sep 2023. She has earned $13,831,848 from insider trading and has received compensation worth at least $6,744,150 in Seagen Inc..

What is the salary of Jean I. Liu J.D., M.S.?

Ms. Jean I. Liu J.D., M.S. salary is $963,450 per year as Chief Legal Officer in Seagen Inc..

How old is Jean I. Liu J.D., M.S.?

Ms. Jean I. Liu J.D., M.S. is 57 years old, born in 1968.

What stocks does Jean I. Liu J.D., M.S. currently own?

As insider, Ms. Jean I. Liu J.D., M.S. owns shares in one company:

Company Title Shares Price per share Total value
Seagen Inc. (SGEN) Chief Legal Officer 84,398 $0 $0

What does Seagen Inc. do?

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

SGEN logo
SGEN
Seagen Inc.

Jean I. Liu J.D., M.S. insider trading

Seagen Inc.

Ms. Jean I. Liu J.D., M.S. has made 34 insider trades between 2018-2023, according to the Form 4 filled with the SEC. Most recently she sold 64 units of SGEN stock worth $13,216 on 21 Sep 2023.

The largest trade she's ever made was exercising 34,876 units of SGEN stock on 1 Nov 2021. As of 21 Sep 2023 she still owns at least 84,398 units of SGEN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 64 $206.5 $13,216
Sale
Common Stock 1,893 $206.97 $391,787
Sale
Common Stock 405 $206 $83,430
Sale
Common Stock 5,000 $205.86 $1,029,310
Option
Common Stock 5,000 $39.15 $195,750
Option
Non-Qualified Stock Option (right to buy) 5,000 $39.15 $195,750
Sale
Common Stock 174 $205.86 $35,819
Option
Non-Qualified Stock Option (right to buy) 5,000 $39.15 $195,750
Option
Common Stock 5,000 $39.15 $195,750
Sale
Common Stock 5,000 $199.9 $999,500
Option
Common Stock 5,000 $39.15 $195,750
Sale
Common Stock 5,000 $155 $775,000
Option
Non-Qualified Stock Option (right to buy) 5,000 $39.15 $195,750
Sale
Common Stock 5,000 $135.03 $675,135
Option
Common Stock 5,000 $39.15 $195,750
Option
Non-Qualified Stock Option (right to buy) 5,000 $39.15 $195,750
Sale
Common Stock 578 $130.71 $75,548
Option
Common Stock 4,525 $39.15 $177,154
Sale
Common Stock 4,525 $135 $610,875
Option
Non-Qualified Stock Option (right to buy) 4,525 $39.15 $177,154
Option
Common Stock 475 $39.15 $18,596
Sale
Common Stock 475 $135 $64,125
Option
Non-Qualified Stock Option (right to buy) 475 $39.15 $18,596
Option
Common Stock 8,333 $34.2 $284,989
Option
Non-Qualified Stock Option (right to buy) 8,333 $34.2 $284,989
Sale
Common Stock 8,333 $131.05 $1,092,056
Option
Common Stock 1,301 $76.86 $99,995
Option
Incentive Stock Option (right to buy) 1,301 $76.86 $99,995
Sale
Common Stock 1,893 $154.42 $292,308
Sale
Common Stock 1,755 $154.42 $270,998
Sale
Common Stock 717 $170.22 $122,044
Sale
Common Stock 922 $170.22 $156,938
Sale
Common Stock 401 $144.32 $57,872
Sale
Common Stock 276 $149.85 $41,359
Option
Incentive Stock Option (right to buy) 1,617 $46.37 $74,980
Option
Common Stock 1,617 $46.37 $74,980
Option
Non-Qualified Stock Option (right to buy) 34,876 $35.95 $1,253,792
Option
Common Stock 34,876 $35.95 $1,253,792
Sale
Common Stock 34,876 $176.13 $6,142,710
Sale
Common Stock 3,648 $167.52 $611,098
Sale
Common Stock 718 $154.55 $110,970
Sale
Common Stock 1,061 N/A N/A
Option
Common Stock 4,846 $42.54 $206,149
Option
Common Stock 4,846 $42.54 $206,149
Option
Incentive Stock Option (right to buy) 2,639 $23.19 $61,185
Option
Incentive Stock Option (right to buy) 2,639 $41.16 $108,621
Option
Common Stock 5,000 $35.95 $179,750
Sale
Common Stock 5,000 $35.95 $179,750
Option
Non-Qualified Stock Option (right to buy) 5,000 N/A N/A
Option
Common Stock 1,624 N/A N/A
Option
Incentive Stock Option (right to buy) 1,624 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Option
Common Stock 9,954 N/A N/A
Option
Incentive Stock Option (right to buy) 9,954 N/A N/A
Sale
Common Stock 11,610 N/A N/A
Sale
Common Stock 3,648 N/A N/A
Sale
Common Stock 6,846 N/A N/A
Sale
Common Stock 9,877 N/A N/A
Sale
Common Stock 7,432 N/A N/A
Sale
Common Stock 1,779 N/A N/A
Sale
Common Stock 6,013 N/A N/A
Sale
Common Stock 3,716 N/A N/A
Sale
Common Stock 3,716 N/A N/A
Sale
Common Stock 4,123 N/A N/A

Seagen key executives

Seagen Inc. executives and other stock owners filed with the SEC: